
NF-κB levels in the liver of young rats with endotoxemic liver injury
HU Ze-Hua, WANG Lin-Lin, TANG Qing, SHAN Qing-Wen, LIAN Shu-Jun, CHEN Ping, CHEN Xiu-Qi
Chinese Journal of Contemporary Pediatrics ›› 2010, Vol. 12 ›› Issue (10) : 804-808.
NF-κB levels in the liver of young rats with endotoxemic liver injury
[1]Xu FL, You HB, Li XH, Chen XF, Liu ZJ, Gong JP. Glycine attenuates endotoxin-induced liver injury by downregulating TLR4 signaling in Kupffer cells[J]. Am J Surg, 2008, 196(1): 139-148.
[2]Zhang D, Jiang J, Jiang S, Ma J, Su T, Qiu L, et al. Molecular characterization and expression analysis of a putative LPS-induced TNF-alpha factor (LITAF) from pearl oyster Pinctada fucata[J]. Fish Shellfish Immunol, 2009, 27(3): 391-396.
[3]谢国旗,蒋建新,陈永华,刘大威,朱佩芳,王正国.内毒素致急性肝损伤机制的实验研究[J].中华急诊医学杂志,2002,11(1):6-9.
[4]Camargo CA, Madden JF, Gao W, Selvan RS, Clavien PA. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent[J]. Hepatology, 1997, 26(6): 1513-1520.
[5]Wang YY, Dahle MK, Steffensen KR, Reinholt FP, Collins JL, Thiemermann C, et al. Liver X receptor agonist GW3965 dose-dependently regulates lps-mediated liver injury and modulates posttranscriptional TNF-alpha production and p38 mitogen-activated protein kinase activation in liver macrophages[J]. Shock, 2009, 32(5): 548-553.
[6]Thomson RK, Arthur MJ. Mechanisms of liver cell damage and repair[J]. Eur J Gastroenterol Hepatol, 1999, 11(9): 949-955.
[7]Shibayama Y, Asaka S, Nishijima A, Nakata K. A study of endotoxin-associated hepatotoxicity on proliferating hepatocytes[J]. Exp Mol Pathol, 1992, 56(1): 70-75.
[8]Ishii K, Ito Y, Katagiri H, Matsumoto Y, Kakita A, Majima M. Neutrophil elastase inhibitor attenuates lipopolysaccharide-induced hepatic microvascular dysfunction in mice[J]. Shock, 2002, 18(2): 163-168.
[9]Qiu Z, Kwon AH, Tsuji K, Kamiyama Y, Okumura T, Hirao Y. Fibronectin prevents D-galactosamine /lipopolysaccharide-induced lethal hepatic failure in mice[J]. Shock, 2006, 25(1): 80-87.
[10]Dhainaut JF, Marin N, Mignon A, Vinsonneau C. Hepatic response to sepsis: interaction between coagulation and inflammatory[J]. Crit Care Med, 2001, 29(7 Suppl): S42-47.
[11]Amacher DE. A toxicologist′s guide to biomarkers of hepatic response[J]. Hum Exp Toxicol, 2002, 21(5): 253-262.
[12]Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S. The current state of serum biomarkers of hepatotoxicity[J]. Toxicology, 2008, 245(3): 194-205.
[13]Monsalve E, Ruiz-García A, Baladrón V, Ruiz-Hidalgo MJ, Sánchez-Solana B, Rivero S, et al. Notch1 upregulates LPS-induced macrophage activation by increasing NF-kappaB activity[J]. Eur J Immunol, 2009, 39(9): 2556-2570.
[14]Maeda S, Hikiba Y, Sakamoto K, Nakagawa H, Hirata Y, Hayakawa Y, et al. Ikappa B kinasebeta/nuclear factor-kappaB activation controls the development of liver metastasis by way of interleukin-6 expression[J]. Hepatology, 2009, 50(6): 1851-1860.
[15]Blackwell TS, Christman JW. The role of nuclear factor-kappa B in cytokine gene regulation[J]. Am J Respir Cell Mol Biol, 1997, 17(1): 3-9.
[16]Sethi G, Ahn KS, Aggarwal BB. Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis[J]. Mol Cancer Res, 2008, 6(6): 1059-1070.
[17]Ciucci A, Gianferretti P, Piva R, Guyot T, Snape TJ, Roberts SM, et al. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway[J]. Mol Pharmacol, 2006, 70(5): 1812-1821.
[18]王永堂,鲁秀敏,李关荣. 内毒素肝损伤过程中NF-κB和AP-1活性变化及其对IL-6表达的调控[J]. 世界华人消化杂志, 2002, 10(7): 787-791.
[19]Lin ST, Wang Y, Xue Y, Feng DC, Xu Y, Xu LY. Tetrandrine suppresses LPS-induced astrocyte activation via modulating IKKs-IkappaBalpha-NF-kappaB signaling pathway[J]. Mol Cell Biochem, 2008, 315(1-2): 41-94.
[20]Jeschke MG, Barrow RE, Suzuki F, Rai J, Benjamin D, Herndon DN. IGF-I/IGFBP-3 equilibrates ratios of pro-to anti-inflammatory cytokines, which are predictors for organ function in severely burned pediatric patients[J]. Mol Med, 2002, 8(5): 238-246.